title: Should azithromycin 1 g be abandoned as a treatment for bacterial STIs? The case for and against.
authors.affiliation: School of Social and Community Medicine, University of Bristol, Bristol, UK.|National Institute for Health Research Health Protection Research Unit (NIHR HPRU), Evaluation of Interventions in Partnership with Public Health England, University of Bristol, Bristol, UK.
authors.forename: Patrick
authors.initials: P
authors.lastname: Horner
authors.affiliation: HIV & STI Department, National Infection Service, Public Health England, London, UK.
authors.forename: John
authors.initials: J
authors.lastname: Saunders
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D017963:Azithromycin / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D024881:Drug Resistance, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D015231:Sexually Transmitted Diseases, Bacterial / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D017963:Azithromycin
keywords: ANTIBIOTICS; ANTIMICROBIAL RESISTANCE; AZITHROMYCIN; BACTERIAL INFECTION